- Home
- UPLD vs DXR Comparison
UPLD vs DXR Comparison
Compare UPLD & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- DXR
- Stock Information
- Founded
- UPLD 2010
- DXR 1970
- Country
- UPLD United States
- DXR United States
- Employees
- UPLD N/A
- DXR N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- DXR Medical/Dental Instruments
- Sector
- UPLD Technology
- DXR Health Care
- Exchange
- UPLD Nasdaq
- DXR Nasdaq
- Market Cap
- UPLD 52.9M
- DXR 46.9M
- IPO Year
- UPLD 2014
- DXR N/A
- Fundamental
- Price
- UPLD $1.82
- DXR $12.79
- Analyst Decision
- UPLD Strong Buy
- DXR Strong Buy
- Analyst Count
- UPLD 1
- DXR 1
- Target Price
- UPLD $4.50
- DXR $25.00
- AVG Volume (30 Days)
- UPLD 159.7K
- DXR 5.7K
- Earning Date
- UPLD 11-06-2025
- DXR 01-01-0001
- Dividend Yield
- UPLD N/A
- DXR N/A
- EPS Growth
- UPLD N/A
- DXR 3.46
- EPS
- UPLD N/A
- DXR 0.36
- Revenue
- UPLD $235,591,000.00
- DXR $66,306.00
- Revenue This Year
- UPLD N/A
- DXR N/A
- Revenue Next Year
- UPLD N/A
- DXR N/A
- P/E Ratio
- UPLD N/A
- DXR $35.89
- Revenue Growth
- UPLD N/A
- DXR N/A
- 52 Week Low
- UPLD $1.62
- DXR $6.55
- 52 Week High
- UPLD $5.64
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- UPLD 38.89
- DXR 48.84
- Support Level
- UPLD $1.70
- DXR $12.52
- Resistance Level
- UPLD $1.96
- DXR $13.49
- Average True Range (ATR)
- UPLD 0.15
- DXR 0.49
- MACD
- UPLD 0.00
- DXR -0.07
- Stochastic Oscillator
- UPLD 37.74
- DXR 64.14
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.